Vor Biopharma ( (VOR) ) has provided an update.
On March 31, 2025, Eyal C. Attar, M.D., announced his resignation as Chief Medical Officer of Vor Biopharma Inc., effective April 18, 2025, to pursue a new opportunity. Vor Biopharma plans to enter into a consulting agreement with Dr. Attar for transition services, acknowledging his contributions to the company.
More about Vor Biopharma
YTD Price Performance: -43.39%
Average Trading Volume: 463,757
Technical Sentiment Signal: Strong Buy
Current Market Cap: $77.41M
For detailed information about VOR stock, go to TipRanks’ Stock Analysis page.